|
|
|
Feed Submission If you'd like OHCNetwork Health News to link to your health news or blog from this category (Headache and Migraine - Diseases and Conditions), please submit your RSS or XML feed to OHCNetwork Health News. Contact information is available here. |
Health News >> Diseases and Conditions >> Headache and Migraine
Categories
|
Migraine ... |
Tension ... |
Headache and Migraine News
Headache / Migraine News From Medical News Today
A novel therapy using a miniature nerve stimulator instead of medication for the treatment of profoundly disabling headache disorders improved the experience of pain by 80-95 percent, according to a new study from the University of California, San Francisco and the National Hospital for Neurology and Neurosurgery in London.
Headache / Migraine News From Medical News Today
Although exacerbation of UC usually poses little diagnostic dilemma, physicians should remain cognizant to the possibility of an alternative cause for patient symptoms. An article published in the World Journal of Gastroenterology addresses this report. The research team led by Prof.
Headache / Migraine News From Medical News Today
Children who suffer from bouts of allergic rhinitis (hay fever) are also more likely to suffer from headaches, facial pain, and ear aches than children without these allergies, says new research presented at the 2008 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in Chicago, IL. Allergic rhinitis is a collection of symptoms predominantly in the nose and eyes, caused by airborne particles of dust, dander, or plant pollens.
Headache / Migraine News From Medical News Today
The Migraine Research Foundation (MRF), the largest nonprofit funder of migraine research in the United States, today announced the winners of its second round of grants intended to spur innovation in migraine research. The grants totaled $200,000. The grantees were screened by MRF's medical advisory board, which is composed of leading scientists and clinicians from across the country.
Headache / Migraine News From Medical News Today
People with migraines may also be more likely to develop blood clots in their veins, according to a study published in the September 16, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. In the condition, called venous thrombosis or thromboembolism, blood clots form in a vein, which can limit blood flow and cause swelling and pain. Those clots can then dislodge from the vein and travel to the heart and the lungs, which can be fatal.
Headache / Migraine News From Medical News Today
Merck Sharp & Dohme Limited announced that in a Phase III clinical trial telcagepant (formerly known as MK-0974) - an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist - significantly relieved moderate-to-severe migraine attacks, including migraine pain and migraine-associated symptoms, compared to placebo. In addition, the overall rates of adverse events in this trial were similar for telcagepant and placebo.
Headache / Migraine News From Medical News Today
Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard today. Professor Tobias Kurth, a leading neuroepidemiologist from Harvard Medical School, USA, has found the links between migraine with aura and cardiovascular events are now so strong that GPs need to take them seriously.
Headache / Migraine News From Medical News Today
CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced Phase II results of its lead compound COL-144 in the treatment of acute migraine. Results demonstrated that COL-144 was safe and effective in relieving migraine headaches. COL-144 is a first-in-class Neurally Acting Anti- Migraine Agent (NAAMA), which unlike triptans, exhibits anti-migraine activity without causing vasoconstriction.
Headache / Migraine News From Medical News Today
Results from a new pooled data analysis presented at the European Headache and Migraine Trust International Congress (EHMTIC) 2008 today show that zolmitriptan ('Zomig') nasal spray provided fast and efficacious relief in the treatment of episodic and chronic cluster headache.
Headache / Migraine News From Medical News Today
NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan (Sumatriptan OS) compared to sumatriptan tablets, marketed as Imitrex®/Imigran®, the leading triptan indicated for the treatment of migraine headaches.
Headache / Migraine News From Medical News Today
Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees. The U.S.
Headache / Migraine News From Medical News Today
Tao Lin, D.V.M., and Steven J. Norris, Ph.D., both with the Department of Pathology and Laboratory Medicine at The University of Texas Medical School at Houston, have been named grant recipients of the Norman Hackerman Advanced Research Program (ARP) by the Texas Higher Education Coordinating Board.
Headache / Migraine News From Medical News Today
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.
Headache / Migraine News From Medical News Today
Women who experience migraine with aura appear to be at an increased risk of heart disease and stroke if they have a certain gene, according to a study published in the July 30, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers followed 25,001 Caucasian women for the occurrence of cardiovascular disease, including heart attacks and ischemic stroke.
Headache / Migraine News From Medical News Today
Treatment of concussions remains arguably the most complex and controversial issue in sports medicine for athletes of all ages, yet concussions occur in millions of athletes each year. The good news is that new scientific research continues to provide clearer knowledge for team doctors and athletic trainers, helping them to recognize and quantify the symptoms and effects of concussions.
Headache / Migraine News From Medical News Today
1. Hodgkin CHuxley Model of Backpropagating Spikes Yuguo Yu, Yousheng Shu, and David A. McCormick Axon potentials recorded in somata of pyramidal neurons in vivo have a fast rising phase and variable threshold, contrary to predictions of the Hodgkin¨CHuxley model. Some have suggested that this difference is due to cooperativity among sodium channels, resulting in many channels opening simultaneously. Yu et al.
Headache / Migraine News From Medical News Today
Two types of oxygen therapy could offer some relief to adults who suffer from disabling migraine and cluster headaches, according to a new research review from Australia. Migraine headaches are severely painful and usually occur with other symptoms such as nausea, vomiting and painful sensitivity to light. Cluster headaches cause sharp, burning pain on one side of the head.
Headache / Migraine News From Medical News Today
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced it has initiated its Phase 3 clinical program to evaluate MAP0004 as a potential treatment for migraine. MAP0004 is orally inhaled and self-administered at home using MAP Pharmaceuticals' proprietary Tempo(R) inhaler. In the company's prior Phase 2 efficacy study, MAP0004 provided pain relief in as fast as 10 minutes, with relief sustained through at least 24 hours.
Headache / Migraine News From Medical News Today
A panel of experts that advises the US Food and Drug Administration (FDA) voted last week to reject the Agency's proposal to make manufacturers of 11 epilepsy drugs put the strongest level of warning label on their products (the Black Box warning). The FDA had recommended the Black Box warning because studies showed the drugs had nearly double the risk of suicide compared to placebo, although in absolute terms it was still quite small.
Headache / Migraine News From Medical News Today
Female soccer players and soccer players who have had a previous concussion recuperate differently from males or players without a history of concussion, new research released at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at JW Marriott Orland Grande Lakes shows. The study found that prior history of concussion and gender account for significant differences in test results following the injury.
Headache / Migraine News From Medical News Today
A combination drug taken within an hour after the start of a migraine is effective in relieving symptoms, according to research published in the July 8, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
Headache / Migraine News From Medical News Today
NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development.
Headache / Migraine News From Medical News Today
Nearly everyone has experienced the acute, short-lived pain that occurs after a mild injury, but recent surveys reveal that more than 20% of the population has a chronic pain condition (i.e., pain that has lasted for 3 months or more) and for which treatment is often not very effective (e.g., low back pain, fibromyalgia, migraine headaches). Acute and chronic pain conditions have huge socio-economic costs.
Headache / Migraine News From Medical News Today
Fifteen percent to 20 percent of people worldwide suffer from migraines excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder. In the Proceedings of the National Academy of Sciences, Alfred George Jr., M.D.
Headache / Migraine News From Medical News Today
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
MedicineNet Migraine General
Title: Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Category: Diseases and Conditions
Created: 11/8/1998 8:47:00 PM
Last Editorial Review: 9/30/2008
Category: Diseases and Conditions
Created: 11/8/1998 8:47:00 PM
Last Editorial Review: 9/30/2008
MedicineNet Migraine General
Title: Headache
Category: Diseases and Conditions
Created: 5/31/2002
Last Editorial Review: 9/30/2008
Category: Diseases and Conditions
Created: 5/31/2002
Last Editorial Review: 9/30/2008
MedicineNet Migraine General
Title: Migraines More Frequent, Intense in Overweight Kids
Category: Health News
Created: 9/27/2008 2:00:00 AM
Last Editorial Review: 9/29/2008
Category: Health News
Created: 9/27/2008 2:00:00 AM
Last Editorial Review: 9/29/2008
MedicineNet Migraine General
Title: Temporomandibular Joint Disorder (TMJ)
Category: Diseases and Conditions
Created: 3/26/1998 2:30:00 PM
Last Editorial Review: 9/26/2008
Category: Diseases and Conditions
Created: 3/26/1998 2:30:00 PM
Last Editorial Review: 9/26/2008
MedicineNet Migraine General
Title: Hypoparathyroidism
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/24/2008
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/24/2008
MedicineNet Migraine General
Title: Cocaine and Crack Abuse
Category: Diseases and Conditions
Created: 10/10/2002
Last Editorial Review: 9/22/2008
Category: Diseases and Conditions
Created: 10/10/2002
Last Editorial Review: 9/22/2008
MedicineNet Migraine General
Title: Acupuncture Cuts Ails of Breast Cancer Drugs
Category: Health News
Created: 9/22/2008
Last Editorial Review: 9/22/2008
Category: Health News
Created: 9/22/2008
Last Editorial Review: 9/22/2008
MedicineNet Migraine General
Title: Migraines Linked to Vein Blood Clots
Category: Health News
Created: 9/16/2008
Last Editorial Review: 9/16/2008
Category: Health News
Created: 9/16/2008
Last Editorial Review: 9/16/2008
MedicineNet Migraine General
Title: Gardasil Approved to Target More Cancers
Category: Health News
Created: 9/15/2008
Last Editorial Review: 9/15/2008
Category: Health News
Created: 9/15/2008
Last Editorial Review: 9/15/2008
MedicineNet Migraine General
Title: Vaccination FAQs
Category: Procedures and Tests
Created: 9/12/2008
Last Editorial Review: 9/12/2008
Category: Procedures and Tests
Created: 9/12/2008
Last Editorial Review: 9/12/2008
MedicineNet Migraine General
Title: gabapentin, Neurontin, Gabarone
Category: Medications
Created: 12/31/1997
Last Editorial Review: 9/10/2008
Category: Medications
Created: 12/31/1997
Last Editorial Review: 9/10/2008
MedicineNet Migraine General
Title: Health Tip: Know the Signs of Concussion
Category: Health News
Created: 9/4/2008 2:00:00 AM
Last Editorial Review: 9/4/2008
Category: Health News
Created: 9/4/2008 2:00:00 AM
Last Editorial Review: 9/4/2008
| ||||||||||||||||||
| ||||||||||||||||||